Pub Date : 2024-10-17eCollection Date: 2024-01-01DOI: 10.1177/26334941241289552
Robert Edilu, Aaron Sanvu, James Ecuut, Alban Odong, Felix Bongomin, Ritah Nantale, Jackline Ayikoru, Baifa Arwinyo, Sande Ojara, Pebalo Francis Pebolo
Background: Cesarean section poses a fourfold risk for postpartum hemorrhage (PPH), necessitating accurate blood loss estimation to enable timely interventions. However, the conventional visual estimation method often leads to underestimation, resulting in undiagnosed PPH even in our setting, Uganda. Yet, the quantitative standard techniques remain underutilized.
Objective: We compared visual and calculated blood loss among women undergoing cesarean delivery at Gulu Regional Referral Hospital in northern Uganda.
Design: We employed a cross-sectional study design.
Methods: We enrolled pregnant women scheduled for cesarean section and determined both calculated and visually estimated blood loss. Data analysis involved using Pearson's moment correlation coefficient to compare the two methods and logistic regression to determine the factors associated with PPH.
Results: We included 105 participants, most were primigravida (n = 100, 43%), aged 15-24 years (n = 100, 52%), with term gestation (n = 100, 75%). The mean visual estimated blood loss (vEBL) was 235.3 ± 123.7 ml (interquartile range (IQR) 50-600 ml), while the calculated estimated blood loss (cEBL) was 435.0 ± 1328.2 ml (IQR -11,182.1-2226.7 ml). Visual estimation underestimated blood loss in 90% of cases (n = 100), and 21% (n = 21) had undiagnosed PPH (>1000 ml blood loss). None of the respondents had PPH (>1000 ml blood loss) following vEBL. There was a small positive correlation between both methods (vEBL and cEBL; r = 0.1165; p = 0.2482). Women aged >35 years were 1.60 times more likely to experience PPH than their counterparts aged 25-34 years (adjusted odds ratio (AOR): 1.60; 95% CI: 1.11-2.30, p < 0.011). Chorioamnionitis increased the risk of PPH by 2.2 times (AOR: 2.20; 95% CI: 1.20-4.05, p < 0.012).
Conclusion: The visual estimation technique significantly underestimated blood loss in up to 90% of cases, particularly during emergency cesarean sections. Among the 21% of cases diagnosed with PPH based on calculated blood loss, advanced maternal age and chorioamnionitis were notable contributing factors. Routine hemoglobin and hematocrit testing in obstetric care can be effectively utilized to objectively assess blood loss, aiding in the accurate diagnosis and management of PPH. Implementing these measures, even in resource-constrained settings, can significantly reduce the morbidity and mortality associated with PPH.
{"title":"Comparing visual estimation and hematocrit change in the assessment of blood loss among women undergoing cesarean delivery in a tertiary facility in northern Uganda.","authors":"Robert Edilu, Aaron Sanvu, James Ecuut, Alban Odong, Felix Bongomin, Ritah Nantale, Jackline Ayikoru, Baifa Arwinyo, Sande Ojara, Pebalo Francis Pebolo","doi":"10.1177/26334941241289552","DOIUrl":"10.1177/26334941241289552","url":null,"abstract":"<p><strong>Background: </strong>Cesarean section poses a fourfold risk for postpartum hemorrhage (PPH), necessitating accurate blood loss estimation to enable timely interventions. However, the conventional visual estimation method often leads to underestimation, resulting in undiagnosed PPH even in our setting, Uganda. Yet, the quantitative standard techniques remain underutilized.</p><p><strong>Objective: </strong>We compared visual and calculated blood loss among women undergoing cesarean delivery at Gulu Regional Referral Hospital in northern Uganda.</p><p><strong>Design: </strong>We employed a cross-sectional study design.</p><p><strong>Methods: </strong>We enrolled pregnant women scheduled for cesarean section and determined both calculated and visually estimated blood loss. Data analysis involved using Pearson's moment correlation coefficient to compare the two methods and logistic regression to determine the factors associated with PPH.</p><p><strong>Results: </strong>We included 105 participants, most were primigravida (<i>n</i> = 100, 43%), aged 15-24 years (<i>n</i> = 100, 52%), with term gestation (<i>n</i> = 100, 75%). The mean visual estimated blood loss (vEBL) was 235.3 ± 123.7 ml (interquartile range (IQR) 50-600 ml), while the calculated estimated blood loss (cEBL) was 435.0 ± 1328.2 ml (IQR -11,182.1-2226.7 ml). Visual estimation underestimated blood loss in 90% of cases (<i>n</i> = 100), and 21% (<i>n</i> = 21) had undiagnosed PPH (>1000 ml blood loss). None of the respondents had PPH (>1000 ml blood loss) following vEBL. There was a small positive correlation between both methods (vEBL and cEBL; <i>r</i> = 0.1165; <i>p</i> = 0.2482). Women aged >35 years were 1.60 times more likely to experience PPH than their counterparts aged 25-34 years (adjusted odds ratio (AOR): 1.60; 95% CI: 1.11-2.30, <i>p</i> < 0.011). Chorioamnionitis increased the risk of PPH by 2.2 times (AOR: 2.20; 95% CI: 1.20-4.05, <i>p</i> < 0.012).</p><p><strong>Conclusion: </strong>The visual estimation technique significantly underestimated blood loss in up to 90% of cases, particularly during emergency cesarean sections. Among the 21% of cases diagnosed with PPH based on calculated blood loss, advanced maternal age and chorioamnionitis were notable contributing factors. Routine hemoglobin and hematocrit testing in obstetric care can be effectively utilized to objectively assess blood loss, aiding in the accurate diagnosis and management of PPH. Implementing these measures, even in resource-constrained settings, can significantly reduce the morbidity and mortality associated with PPH.</p><p><strong>Trial registration: </strong>Not applicable.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-17eCollection Date: 2024-01-01DOI: 10.1177/26334941241289553
Methembe Yotamu Khozah, Wilfred Njabulo Nunu
Background: Reproductive healthcare is essential for all people, including lesbian and bisexual women. However, lesbians and bisexual women are among society's most marginalised and excluded members.
Objective: This study aimed to explore the challenges faced by lesbian and bisexual women in accessing Sexual and Reproductive Health (SRH) Services in Bulawayo, Zimbabwe.
Design: An exploratory, descriptive qualitative study was conducted on two populations that included eight participants identified through the Voice of the Voiceless organisation in Bulawayo and 10 key informants and probed the challenges faced by lesbians and bisexual women when accessing SRH services.
Methods: Data were gathered through 10 key informant interviews and 1 focus group discussion (FGD; with 8 participants). The interviews and FGDs were recorded, transcribed verbatim, coded and thematically analysed.
Results: The themes that emerged included the uptake of SRH services among lesbians and bisexual women, the challenges faced by lesbians and bisexual women when accessing SRH services, and strategies to aid the uptake of SRH services by lesbians and bisexual women. The findings showed that the uptake of SRH services was generally low and was influenced by factors such as clinical settings. The challenges mentioned included stigma and the unavailability of specific lesbian and bisexual women's services. By contrast, the most frequent strategies included affirmative training for healthcare providers and improved clinical settings to become friendly and inclusive.
Conclusion: There is an imperative for targeted SRH services that address the distinct needs of lesbians and bisexual women, in line with the 95-95-95 strategy and Sustainable Development Goals target 3.7. The observed low uptake of these services can be attributed to several systemic barriers, including inadequate training of health providers, negative attitudes and lack of inclusive policies. Enhancing the sensitivity of health facilities, strengthening links to sexual health education and implementing supportive legal frameworks are essential steps to improve SRH outcomes in this population. These findings elucidate critical gaps within the current healthcare system and present significant opportunities for policymakers to formulate evidence-based strategies to ensure equitable access to SRH services, thereby advancing public health objectives.
{"title":"Exploring challenges to the uptake of sexual and reproductive health services among lesbian and bisexual women in Bulawayo, Zimbabwe: a qualitative enquiry.","authors":"Methembe Yotamu Khozah, Wilfred Njabulo Nunu","doi":"10.1177/26334941241289553","DOIUrl":"10.1177/26334941241289553","url":null,"abstract":"<p><strong>Background: </strong>Reproductive healthcare is essential for all people, including lesbian and bisexual women. However, lesbians and bisexual women are among society's most marginalised and excluded members.</p><p><strong>Objective: </strong>This study aimed to explore the challenges faced by lesbian and bisexual women in accessing Sexual and Reproductive Health (SRH) Services in Bulawayo, Zimbabwe.</p><p><strong>Design: </strong>An exploratory, descriptive qualitative study was conducted on two populations that included eight participants identified through the Voice of the Voiceless organisation in Bulawayo and 10 key informants and probed the challenges faced by lesbians and bisexual women when accessing SRH services.</p><p><strong>Methods: </strong>Data were gathered through 10 key informant interviews and 1 focus group discussion (FGD; with 8 participants). The interviews and FGDs were recorded, transcribed verbatim, coded and thematically analysed.</p><p><strong>Results: </strong>The themes that emerged included the uptake of SRH services among lesbians and bisexual women, the challenges faced by lesbians and bisexual women when accessing SRH services, and strategies to aid the uptake of SRH services by lesbians and bisexual women. The findings showed that the uptake of SRH services was generally low and was influenced by factors such as clinical settings. The challenges mentioned included stigma and the unavailability of specific lesbian and bisexual women's services. By contrast, the most frequent strategies included affirmative training for healthcare providers and improved clinical settings to become friendly and inclusive.</p><p><strong>Conclusion: </strong>There is an imperative for targeted SRH services that address the distinct needs of lesbians and bisexual women, in line with the 95-95-95 strategy and Sustainable Development Goals target 3.7. The observed low uptake of these services can be attributed to several systemic barriers, including inadequate training of health providers, negative attitudes and lack of inclusive policies. Enhancing the sensitivity of health facilities, strengthening links to sexual health education and implementing supportive legal frameworks are essential steps to improve SRH outcomes in this population. These findings elucidate critical gaps within the current healthcare system and present significant opportunities for policymakers to formulate evidence-based strategies to ensure equitable access to SRH services, thereby advancing public health objectives.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-15eCollection Date: 2024-01-01DOI: 10.1177/26334941241288587
Obasanjo Afolabi Bolarinwa, Aliu Mohammed, Victor Igharo
{"title":"The role of artificial intelligence in transforming maternity services in Africa: prospects and challenges.","authors":"Obasanjo Afolabi Bolarinwa, Aliu Mohammed, Victor Igharo","doi":"10.1177/26334941241288587","DOIUrl":"10.1177/26334941241288587","url":null,"abstract":"","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-09eCollection Date: 2024-01-01DOI: 10.1177/26334941241288841
Chinedu L Olisa, Betrand O Nwosu, George U Eleje, Charlotte B Oguejiofor, Innocent I Mbachu, Chukwudi A Ogabido, Tobechi K Njoku, Chidinma C Okafor, Zebulon C Okechukwu, Chukwunwendu F Okeke, Ifeanyi O Okonkwo, Emmanuel I Okaforcha, Chukwunonso I Enechukwu, Chito P Ilika, Obinna K Nnabuchi, Ugochukwu H Osuafor, Harrison C Ugwuoroko, Emmanuel C Egwuatu, Martin C Andeh, Chigozie G Okafor
<p><strong>Background: </strong>Assessing for significant proteinuria in pregnancy (SPIP) stands as a key indicator for diagnosing preeclampsia. However, the initial method typically employed for this assessment, the urine dipstick test, often yields inaccurate results. While a 24-h urine collection is considered the most reliable test, its implementation can lead to delays in diagnosis, potentially affecting both maternal and fetal well-being. The urine protein-creatinine (P/Cr) ratio can be used as an alternative to 24-h urine protein analysis, but its diagnostic accuracy has remained uncertain. There is a need to compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis for SPIP, especially in resource-poor settings.</p><p><strong>Objectives: </strong>To determine and compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis in a spot urine specimen for the diagnosis of SPIP among women evaluated for preeclampsia using 24-h urine protein excretions as a gold standard.</p><p><strong>Design: </strong>This is a comparative cross-sectional study.</p><p><strong>Methods: </strong>The study involved 82 singleton pregnant women evaluated for preeclampsia from 20 weeks of gestation who underwent dipstick and P/Cr ratio tests in the same urine sample. Women at risk of preeclampsia were given a specimen container for the collection of urine samples on an outpatient basis. Participants were trained and told to collect the urine sample 24 h prior to their next antenatal appointment. However, those on admission and evaluated for preeclampsia had their 24-h urine collected in the hospital. The outcome measures included sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio and accuracy for the two tests. Significant proteinuria was defined as a P/Cr ratio >0.27 or ⩾2+ of proteinuria on the dipstick test. Preeclampsia was confirmed in women with both high blood pressure and SPIP.</p><p><strong>Results: </strong>The mean age of participants was 28.65 ± 5.76 years. Comparatively, the diagnostic accuracy (91.46% (95% CI = 83.29-96.59) vs 59.76% (95% CI = 48.34-70.44), <i>p</i> = 0.001), sensitivity (94.74% vs 70.00%, <i>p</i> = 0.021), specificity (84.00% vs 43.75%, <i>p</i> = 0.001), negative predictive value (87.50% vs 48.28%, <i>p</i> = 0.003) and positive predictive value (93.10% vs 66.04%, <i>p</i> = 0.001), respectively, were higher for the spot urine P/Cr ratio than dipstick test. In addition, the positive likelihood ratio and the negative likelihood ratio for spot urine P/Cr ratio versus dipstick test were (1.93 vs 1.24) and (0.07 vs 0.69), respectively.</p><p><strong>Conclusion: </strong>The spot urine P/Cr has superior diagnostic accuracy in the determination of significant proteinuria in pregnant women being evaluated for preeclampsia than the widely used dipstick test. A more robust multicenter study is needed to compare the diagnostic accuracy of spot urine PCR with the st
背景:评估妊娠期大量蛋白尿(SPIP)是诊断子痫前期的一个关键指标。然而,这种评估通常采用的初始方法--尿液浸量棒测试--往往会产生不准确的结果。虽然收集 24 小时的尿液被认为是最可靠的检测方法,但采用这种方法会导致诊断延误,从而可能影响孕妇和胎儿的健康。尿蛋白-肌酐(P/Cr)比值可作为 24 小时尿蛋白分析的替代方法,但其诊断准确性仍不确定。有必要比较尿蛋白/肌酐比值和浸量式尿液分析对 SPIP 的诊断准确性,尤其是在资源匮乏的环境中:以 24 小时尿蛋白排泄量为金标准,确定并比较尿液 P/Cr 比值和点滴尿液标本中沾取的尿液进行 SPIP 诊断的准确性:这是一项横断面比较研究:这项研究涉及 82 名从妊娠 20 周开始接受子痫前期评估的单胎孕妇,她们在同一尿样中接受了浸量尺和 P/Cr 比值检测。有先兆子痫风险的妇女在门诊时会得到一个用于收集尿样的标本容器。参与者接受了培训,并被告知应在下次产前预约前 24 小时采集尿样。然而,那些入院并被评估为子痫前期的患者则在医院收集其 24 小时尿液。结果测量包括两种检测方法的灵敏度、特异性、阳性预测值、阴性预测值、似然比和准确性。明显蛋白尿的定义是 P/Cr 比值大于 0.27,或用浸量棒检测时蛋白尿量⩾2+。同时患有高血压和 SPIP 的妇女被确诊为子痫前期:参与者的平均年龄为 28.65±5.76 岁。相比之下,诊断准确率(91.46% (95% CI = 83.29-96.59) vs 59.76% (95% CI = 48.34-70.44), p = 0.001)、灵敏度(94.74% vs 70.00%, p = 0.021)、特异性(84.00% vs 43.75%, p = 0.001)、阴性预测值(87.50% vs 48.28%,p = 0.003)和阳性预测值(93.10% vs 66.04%,p = 0.001)分别高于点滴试验。此外,定点尿液 P/Cr 比值的阳性似然比和阴性似然比分别为(1.93 vs 1.24)和(0.07 vs 0.69):与广泛使用的量表测试相比,定点尿 P/Cr 在确定评估子痫前期的孕妇是否有明显蛋白尿方面具有更高的诊断准确性。在低收入环境中,需要进行更有力的多中心研究,以比较定点尿液 PCR 与标准 24 小时尿蛋白的诊断准确性。
{"title":"Comparison of urine protein-creatinine ratio and urine dipstick test for significant proteinuria in preeclamptic women.","authors":"Chinedu L Olisa, Betrand O Nwosu, George U Eleje, Charlotte B Oguejiofor, Innocent I Mbachu, Chukwudi A Ogabido, Tobechi K Njoku, Chidinma C Okafor, Zebulon C Okechukwu, Chukwunwendu F Okeke, Ifeanyi O Okonkwo, Emmanuel I Okaforcha, Chukwunonso I Enechukwu, Chito P Ilika, Obinna K Nnabuchi, Ugochukwu H Osuafor, Harrison C Ugwuoroko, Emmanuel C Egwuatu, Martin C Andeh, Chigozie G Okafor","doi":"10.1177/26334941241288841","DOIUrl":"https://doi.org/10.1177/26334941241288841","url":null,"abstract":"<p><strong>Background: </strong>Assessing for significant proteinuria in pregnancy (SPIP) stands as a key indicator for diagnosing preeclampsia. However, the initial method typically employed for this assessment, the urine dipstick test, often yields inaccurate results. While a 24-h urine collection is considered the most reliable test, its implementation can lead to delays in diagnosis, potentially affecting both maternal and fetal well-being. The urine protein-creatinine (P/Cr) ratio can be used as an alternative to 24-h urine protein analysis, but its diagnostic accuracy has remained uncertain. There is a need to compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis for SPIP, especially in resource-poor settings.</p><p><strong>Objectives: </strong>To determine and compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis in a spot urine specimen for the diagnosis of SPIP among women evaluated for preeclampsia using 24-h urine protein excretions as a gold standard.</p><p><strong>Design: </strong>This is a comparative cross-sectional study.</p><p><strong>Methods: </strong>The study involved 82 singleton pregnant women evaluated for preeclampsia from 20 weeks of gestation who underwent dipstick and P/Cr ratio tests in the same urine sample. Women at risk of preeclampsia were given a specimen container for the collection of urine samples on an outpatient basis. Participants were trained and told to collect the urine sample 24 h prior to their next antenatal appointment. However, those on admission and evaluated for preeclampsia had their 24-h urine collected in the hospital. The outcome measures included sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio and accuracy for the two tests. Significant proteinuria was defined as a P/Cr ratio >0.27 or ⩾2+ of proteinuria on the dipstick test. Preeclampsia was confirmed in women with both high blood pressure and SPIP.</p><p><strong>Results: </strong>The mean age of participants was 28.65 ± 5.76 years. Comparatively, the diagnostic accuracy (91.46% (95% CI = 83.29-96.59) vs 59.76% (95% CI = 48.34-70.44), <i>p</i> = 0.001), sensitivity (94.74% vs 70.00%, <i>p</i> = 0.021), specificity (84.00% vs 43.75%, <i>p</i> = 0.001), negative predictive value (87.50% vs 48.28%, <i>p</i> = 0.003) and positive predictive value (93.10% vs 66.04%, <i>p</i> = 0.001), respectively, were higher for the spot urine P/Cr ratio than dipstick test. In addition, the positive likelihood ratio and the negative likelihood ratio for spot urine P/Cr ratio versus dipstick test were (1.93 vs 1.24) and (0.07 vs 0.69), respectively.</p><p><strong>Conclusion: </strong>The spot urine P/Cr has superior diagnostic accuracy in the determination of significant proteinuria in pregnant women being evaluated for preeclampsia than the widely used dipstick test. A more robust multicenter study is needed to compare the diagnostic accuracy of spot urine PCR with the st","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11467826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-23eCollection Date: 2024-01-01DOI: 10.1177/26334941241277759
Ido Mick, Shay M Freger, Jolanda van Keizerswaard, Mahsa Gholiof, Mathew Leonardi
Endometriosis is a prevalent gynecological disease, leading to chronic pain and inflammation, affecting 1 in 10 individuals presumed female at birth. The diagnostic journey is often arduous, marked by neglect of the right diagnosis and prolonged wait times, significantly compromising the quality of life among those affected. This review provides a nuanced exploration of endometriosis-associated pain management, encompassing medical, surgical, and holistic approaches, all guided by accurate and refined diagnostics. Our paramount goal is to empower physicians as key figures in confronting this intricate challenge with a patient-centric approach, ultimately aiming to improve treatment and quality of life. Acknowledging each patient's unique needs, we emphasize the importance of tailoring a spectrum of options informed by current literature and insights gleaned from our experience in a high-volume tertiary endometriosis center. It is imperative to recognize endometriosis as a complex and chronic disease, often occurring with co-morbid conditions and nuanced complexities, necessitating a long-term personalized multimodal approach for each case. In addition, incorporating principles such as patient autonomy, profound respect for diverse experiences, and practical education on treatment choices is pivotal in enhancing treatment outcomes and overall patient satisfaction.
{"title":"Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis.","authors":"Ido Mick, Shay M Freger, Jolanda van Keizerswaard, Mahsa Gholiof, Mathew Leonardi","doi":"10.1177/26334941241277759","DOIUrl":"https://doi.org/10.1177/26334941241277759","url":null,"abstract":"<p><p>Endometriosis is a prevalent gynecological disease, leading to chronic pain and inflammation, affecting 1 in 10 individuals presumed female at birth. The diagnostic journey is often arduous, marked by neglect of the right diagnosis and prolonged wait times, significantly compromising the quality of life among those affected. This review provides a nuanced exploration of endometriosis-associated pain management, encompassing medical, surgical, and holistic approaches, all guided by accurate and refined diagnostics. Our paramount goal is to empower physicians as key figures in confronting this intricate challenge with a patient-centric approach, ultimately aiming to improve treatment and quality of life. Acknowledging each patient's unique needs, we emphasize the importance of tailoring a spectrum of options informed by current literature and insights gleaned from our experience in a high-volume tertiary endometriosis center. It is imperative to recognize endometriosis as a complex and chronic disease, often occurring with co-morbid conditions and nuanced complexities, necessitating a long-term personalized multimodal approach for each case. In addition, incorporating principles such as patient autonomy, profound respect for diverse experiences, and practical education on treatment choices is pivotal in enhancing treatment outcomes and overall patient satisfaction.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-23eCollection Date: 2024-01-01DOI: 10.1177/26334941241271563
Andrea Etrusco, Vittorio Agrifoglio, Antonio Simone Laganà, Elko Gliozheni, Annamaria Caringella, Antonio Stanziano, Ettore Cicinelli, Vito Chiantera, Andrea Giannini, Baydaa Alsannan, Fabio Barra, Antonio D'Amato
Background: Uterine sarcomas (US) are rare cancer of possible occurrence even in women of childbearing age. To date, total hysterectomy is the standard treatment in the early stages. The possibilities of carrying out fertility-sparing treatments (FST) to save the fertility of women with unfulfilled reproductive desires are described in the literature, but to date, they can only be considered experimental.
Objective: The aim of this systematic review was to evaluate the oncological and reproductive outcomes of women with different histological types of US undergoing FST.
Design: Systematic review.
Data sources and methods: Electronic databases were searched for English-language studies describing FST for US until January 31, 2024.
Results: Forty-five papers which met the abovementioned inclusion criteria, were included in the qualitative analysis. Quantitative analysis was not possible because of the heterogeneity of the data. A descriptive summary of the results according to the histotype of US was provided. Six hundred forty-one patients of childbearing age with US and undergoing FST. After treatment with FST, 89 (13.9%) disease recurrences and 107 (16.7%) pregnancies were recorded.
Conclusion: In selected cases of early-stage US, FST may be proposed. However, the patient must be informed of the real possibility of recurrence and potentially difficult achievement of pregnancy. Additional well-designed prospective studies and clinical trials are needed to address the knowledge gaps and enhance clinical decision-making in this population.
Trial registration: PROSPERO ID: CRD42024509356.
背景:子宫肉瘤(US)是一种罕见的癌症,即使在育龄妇女中也有可能发生。迄今为止,全子宫切除术是早期阶段的标准治疗方法。文献中描述了通过保留生育力治疗(FST)来挽救生育愿望未得到满足的妇女的生育力的可能性,但迄今为止,这些治疗只能被认为是实验性的:本系统性综述旨在评估不同组织学类型的 US 妇女接受 FST 治疗后的肿瘤和生育结果:数据来源和方法在电子数据库中搜索了截至2024年1月31日的描述US的FST的英文研究:符合上述纳入标准的 45 篇论文被纳入定性分析。由于数据的异质性,无法进行定量分析。根据美国的组织类型对结果进行了描述性总结。641 名育龄期 US 患者接受了 FST 治疗。经 FST 治疗后,89 例(13.9%)疾病复发,107 例(16.7%)妊娠:结论:在选定的早期 US 病例中,可建议使用 FST。然而,必须告知患者复发的实际可能性以及怀孕的潜在困难。需要进行更多设计良好的前瞻性研究和临床试验,以填补知识空白并加强该人群的临床决策:PROSPERO ID:CRD42024509356。
{"title":"Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review.","authors":"Andrea Etrusco, Vittorio Agrifoglio, Antonio Simone Laganà, Elko Gliozheni, Annamaria Caringella, Antonio Stanziano, Ettore Cicinelli, Vito Chiantera, Andrea Giannini, Baydaa Alsannan, Fabio Barra, Antonio D'Amato","doi":"10.1177/26334941241271563","DOIUrl":"10.1177/26334941241271563","url":null,"abstract":"<p><strong>Background: </strong>Uterine sarcomas (US) are rare cancer of possible occurrence even in women of childbearing age. To date, total hysterectomy is the standard treatment in the early stages. The possibilities of carrying out fertility-sparing treatments (FST) to save the fertility of women with unfulfilled reproductive desires are described in the literature, but to date, they can only be considered experimental.</p><p><strong>Objective: </strong>The aim of this systematic review was to evaluate the oncological and reproductive outcomes of women with different histological types of US undergoing FST.</p><p><strong>Design: </strong>Systematic review.</p><p><strong>Data sources and methods: </strong>Electronic databases were searched for English-language studies describing FST for US until January 31, 2024.</p><p><strong>Results: </strong>Forty-five papers which met the abovementioned inclusion criteria, were included in the qualitative analysis. Quantitative analysis was not possible because of the heterogeneity of the data. A descriptive summary of the results according to the histotype of US was provided. Six hundred forty-one patients of childbearing age with US and undergoing FST. After treatment with FST, 89 (13.9%) disease recurrences and 107 (16.7%) pregnancies were recorded.</p><p><strong>Conclusion: </strong>In selected cases of early-stage US, FST may be proposed. However, the patient must be informed of the real possibility of recurrence and potentially difficult achievement of pregnancy. Additional well-designed prospective studies and clinical trials are needed to address the knowledge gaps and enhance clinical decision-making in this population.</p><p><strong>Trial registration: </strong>PROSPERO ID: CRD42024509356.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-31eCollection Date: 2024-01-01DOI: 10.1177/26334941241271542
Abdul Qadeer, Muhammad Umer Ishaq, Adnan Safi, Anum Akbar, Sana Asif, Aqsa Komel, Digbijay Kunwar, Syed Mujtaba Azhar Bokhari
Gestational diabetes mellitus (GDM) and thyroid disorders during pregnancy pose significant health concerns, impacting a substantial number of mothers globally. Globally, about 14% of pregnant women develop GDM, while thyroid disorders impact approximately 2%-3%. Both conditions contribute to adverse outcomes, including gestational hypertension, excessive fetal growth, and heightened perinatal morbidity. The central focus of this literature review is to examine the relationship between vitamin A, a crucial fat-soluble micronutrient in fetal development, and the occurrence of GDM and thyroid disorders during pregnancy. The primary research question investigates the association between vitamin A, GDM, and thyroid disorders, analyzing their combined impact on maternal, fetal, and neonatal outcomes. The review underscores the potential of vitamin A to modulate the risk and outcomes of GDM and thyroid disorders during gestation, emphasizing its role in GDM development and resolution and its influence on thyroid function in pregnancy.
妊娠期糖尿病(GDM)和妊娠期甲状腺疾病是重大的健康问题,影响着全球大量的母亲。全球约有 14% 的孕妇罹患妊娠期糖尿病,约有 2%-3% 的孕妇受到甲状腺疾病的影响。这两种疾病都会导致不良后果,包括妊娠高血压、胎儿生长过快和围产期发病率增高。本文献综述的重点是研究维生素 A(一种对胎儿发育至关重要的脂溶性微量营养素)与妊娠期 GDM 和甲状腺疾病之间的关系。主要研究问题是调查维生素 A、GDM 和甲状腺疾病之间的关系,分析它们对孕产妇、胎儿和新生儿结局的综合影响。综述强调了维生素 A 调节妊娠期 GDM 和甲状腺疾病的风险和结局的潜力,强调了维生素 A 在 GDM 的发展和缓解中的作用及其对妊娠期甲状腺功能的影响。
{"title":"Association of vitamin A with gestational diabetes and thyroid disorders in pregnancy and their influence on maternal, fetal, and neonatal outcomes.","authors":"Abdul Qadeer, Muhammad Umer Ishaq, Adnan Safi, Anum Akbar, Sana Asif, Aqsa Komel, Digbijay Kunwar, Syed Mujtaba Azhar Bokhari","doi":"10.1177/26334941241271542","DOIUrl":"10.1177/26334941241271542","url":null,"abstract":"<p><p>Gestational diabetes mellitus (GDM) and thyroid disorders during pregnancy pose significant health concerns, impacting a substantial number of mothers globally. Globally, about 14% of pregnant women develop GDM, while thyroid disorders impact approximately 2%-3%. Both conditions contribute to adverse outcomes, including gestational hypertension, excessive fetal growth, and heightened perinatal morbidity. The central focus of this literature review is to examine the relationship between vitamin A, a crucial fat-soluble micronutrient in fetal development, and the occurrence of GDM and thyroid disorders during pregnancy. The primary research question investigates the association between vitamin A, GDM, and thyroid disorders, analyzing their combined impact on maternal, fetal, and neonatal outcomes. The review underscores the potential of vitamin A to modulate the risk and outcomes of GDM and thyroid disorders during gestation, emphasizing its role in GDM development and resolution and its influence on thyroid function in pregnancy.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-20eCollection Date: 2024-01-01DOI: 10.1177/26334941241270372
Taieb Ach, Ayoub Guesmi, Maha Kalboussi, Fatma Ben Abdessalem, Emna Mraihi, Houda El Mhabrech
Background: Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrinopathies among young women. Ultrasound evidence of polycystic ovaries is one of its crucial diagnostic criteria.
Objectives: Our main objective is to study the contribution of ultrasound data in diagnosing PCOS. In addition, we aim to establish a new cutoff point for the use of ultrasound and to determine its sensitivity as well as its specificity.
Design: It was a prospective study, including all patients presenting with clinical hyperandrogenism.
Methods: The ultrasound examination of these patients was performed using a novel ultrasound machine (18 MHz) compared to an older ultrasound machine (2 Hz-8 MHz). Inclusion criteria encompassed adult female patients over 18 years presenting symptoms suggestive of PCOS, particularly hyperandrogenism and oligo-anovulation, meeting Rotterdam's diagnostic criteria. Prior to inclusion, assessments were conducted to eliminate other potential causes explaining hyperandrogenism or menstrual disorders in both groups.
Results: We examined 92 patients diagnosed with PCOS. Menstrual disorders were the main symptoms, with amenorrhea being more frequent in the PCOS group (G1) (48.9% vs the control group (G2): 11.1%). The follicle number was significantly lower in the control group, as assessed by both ultrasound machines (p < 10-3). The accuracy of the new ultrasound device was evaluated compared to the old one using the receiver operating characteristic (ROC) curve, revealing a cutoff of 18 follicles (sensitivity of 68.1%, specificity of 100%) and an area under the curve of 0.955. We found a significant difference between the median values of the number of follicles (NF) by both ultrasound machines (18 vs 12). It was positively correlated with an index of r = 0.916. For the volume, it was distinctively higher in G1 (p < 10-3). ROC curve analysis revealed an ovarian volume cutoff of 9.25 ml with a sensitivity of 48.9% and a specificity of 100%. Both ultrasound machines were positively correlated with an index of r = 0.979 (p < 10-3).
Conclusion: In conclusion, we were able to establish significant correlations between the new and the old ultrasound devices for both the NF and ovarian volume. Our study is distinctive as it represents the first on the African continent to re-evaluate the ultrasound criterion for PCOS.
{"title":"Validation of the follicular and ovarian thresholds by an 18-MHz ultrasound imaging in polycystic ovary syndrome: a pilot cutoff for North African patients.","authors":"Taieb Ach, Ayoub Guesmi, Maha Kalboussi, Fatma Ben Abdessalem, Emna Mraihi, Houda El Mhabrech","doi":"10.1177/26334941241270372","DOIUrl":"10.1177/26334941241270372","url":null,"abstract":"<p><strong>Background: </strong>Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrinopathies among young women. Ultrasound evidence of polycystic ovaries is one of its crucial diagnostic criteria.</p><p><strong>Objectives: </strong>Our main objective is to study the contribution of ultrasound data in diagnosing PCOS. In addition, we aim to establish a new cutoff point for the use of ultrasound and to determine its sensitivity as well as its specificity.</p><p><strong>Design: </strong>It was a prospective study, including all patients presenting with clinical hyperandrogenism.</p><p><strong>Methods: </strong>The ultrasound examination of these patients was performed using a novel ultrasound machine (18 MHz) compared to an older ultrasound machine (2 Hz-8 MHz). Inclusion criteria encompassed adult female patients over 18 years presenting symptoms suggestive of PCOS, particularly hyperandrogenism and oligo-anovulation, meeting Rotterdam's diagnostic criteria. Prior to inclusion, assessments were conducted to eliminate other potential causes explaining hyperandrogenism or menstrual disorders in both groups.</p><p><strong>Results: </strong>We examined 92 patients diagnosed with PCOS. Menstrual disorders were the main symptoms, with amenorrhea being more frequent in the PCOS group (G1) (48.9% vs the control group (G2): 11.1%). The follicle number was significantly lower in the control group, as assessed by both ultrasound machines (<i>p</i> < 10<sup>-3</sup>). The accuracy of the new ultrasound device was evaluated compared to the old one using the receiver operating characteristic (ROC) curve, revealing a cutoff of 18 follicles (sensitivity of 68.1%, specificity of 100%) and an area under the curve of 0.955. We found a significant difference between the median values of the number of follicles (NF) by both ultrasound machines (18 vs 12). It was positively correlated with an index of r = 0.916. For the volume, it was distinctively higher in G1 (<i>p</i> < 10<sup>-3</sup>). ROC curve analysis revealed an ovarian volume cutoff of 9.25 ml with a sensitivity of 48.9% and a specificity of 100%. Both ultrasound machines were positively correlated with an index of r = 0.979 (<i>p</i> < 10<sup>-3</sup>).</p><p><strong>Conclusion: </strong>In conclusion, we were able to establish significant correlations between the new and the old ultrasound devices for both the NF and ovarian volume. Our study is distinctive as it represents the first on the African continent to re-evaluate the ultrasound criterion for PCOS.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Cervical cancer is one of the most common causes of cancer-related morbidity and mortality globally. In developed countries, effective screening programs reduced its burden. However, in Ethiopia, cervical cancer remains a major public health problem despite the screening service being available free of charge.
Objective: The aim of this study was to assess women's willingness for cervical cancer screening services and associated factors among women attending health services in Addis Ababa, Ethiopia.
Design: An institutional-based, analytic, cross-sectional study was conducted among sexually active women attending health facilities from August to September 2022.
Methods: A pretested interviewer-administered questionnaire was used for data collection. Data were analyzed using SPSS version 25. Logistic regression was used to determine different variables' frequencies and associated factors. A p value of <0.05 was considered statistically significant.
Result: Four hundred twenty-two women were approached, and 394 (93.4%) met the study inclusion criteria. Study participants had a minimum of 1 and a maximum of 6 sexual partners in their lives. A total of 256 (64.9%) study participants had heard about cervical cancer. Among those who heard about cervical cancer, only 22 (8.6%) had been tested for cervical cancer. Of those who did not receive cervical cancer screening, only 175 (47.0%) are willing to receive cervical cancer screening. Age, religion, marital status, place of residence, educational level, occupation, and hearing about cervical cancer were found to be statistically significant. Women who heard about cervical cancer were 15.2 times more likely to take the test compared to those who never heard about cervical cancer before the study.
Conclusion: Women's willingness to be screened for cervical cancer is low despite many of the study participants having more than one partner in their lives and being at risk for cervical cancer. Only a few participants had been screened for cervical cancer. Women who had heard about cervical cancer were more likely to take the screening service compared to those who had never heard it before. This highlights the need to prioritize raising awareness about the benefits of cervical cancer screening services.
{"title":"Women's willingness for cervical cancer screening and associated factors among women attending health services in Addis Ababa, Ethiopia.","authors":"Tangute Demas, Teshale Biku, Tewodros Getinet, Bereket Fantahun, Delayehu Bekele, Negat Woldehawariat, Rahel Muzemir, Martha Shoarega","doi":"10.1177/26334941241253181","DOIUrl":"10.1177/26334941241253181","url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer is one of the most common causes of cancer-related morbidity and mortality globally. In developed countries, effective screening programs reduced its burden. However, in Ethiopia, cervical cancer remains a major public health problem despite the screening service being available free of charge.</p><p><strong>Objective: </strong>The aim of this study was to assess women's willingness for cervical cancer screening services and associated factors among women attending health services in Addis Ababa, Ethiopia.</p><p><strong>Design: </strong>An institutional-based, analytic, cross-sectional study was conducted among sexually active women attending health facilities from August to September 2022.</p><p><strong>Methods: </strong>A pretested interviewer-administered questionnaire was used for data collection. Data were analyzed using SPSS version 25. Logistic regression was used to determine different variables' frequencies and associated factors. A <i>p</i> value of <0.05 was considered statistically significant.</p><p><strong>Result: </strong>Four hundred twenty-two women were approached, and 394 (93.4%) met the study inclusion criteria. Study participants had a minimum of 1 and a maximum of 6 sexual partners in their lives. A total of 256 (64.9%) study participants had heard about cervical cancer. Among those who heard about cervical cancer, only 22 (8.6%) had been tested for cervical cancer. Of those who did not receive cervical cancer screening, only 175 (47.0%) are willing to receive cervical cancer screening. Age, religion, marital status, place of residence, educational level, occupation, and hearing about cervical cancer were found to be statistically significant. Women who heard about cervical cancer were 15.2 times more likely to take the test compared to those who never heard about cervical cancer before the study.</p><p><strong>Conclusion: </strong>Women's willingness to be screened for cervical cancer is low despite many of the study participants having more than one partner in their lives and being at risk for cervical cancer. Only a few participants had been screened for cervical cancer. Women who had heard about cervical cancer were more likely to take the screening service compared to those who had never heard it before. This highlights the need to prioritize raising awareness about the benefits of cervical cancer screening services.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-24eCollection Date: 2024-01-01DOI: 10.1177/26334941241251967
Pebalo Francis Pebolo, Jerom Okot, Felix Bongomin, Silvia Awor, Baifa Arwinyo, Sande Ojara, Jimmyy Opee, Ayikoru Jackline, Eric Ssennuni, Simple Ouma
Background: Reproductive health emergencies, such as postpartum hemorrhage, contribute significantly to maternal and neonatal morbidity and mortality in Uganda due to knowledge and skills gaps. Medical interns, intern midwives, and nurses are crucial as frontline healthcare workers in responding to these emergencies. Our proposed hands-on strategy involves comprehensive simulation-based training (SBT) to equip these healthcare workers with the essential knowledge to manage common reproductive health emergencies and procedures in the country.
Objectives: The study aimed to assess the effectiveness of comprehensive SBT in improving the knowledge of interns and fifth-year medical students on reproductive health emergencies and procedures at Gulu University and its Teaching Hospitals in Uganda.
Design: A before-and-after study.
Methods: A 4-day SBT was conducted for fifth-year medical students and interns (nurses, midwives, and doctors) at Gulu University Teaching Hospitals, focusing on reproductive health emergencies. Pre- and post-tests with 40 multiple-choice questions were used to evaluate knowledge enhancement, the scores were summarized as medians and interquartile ranges. Paired sample t-tests was used to test the difference in pre- and post-test scores. Independent sample t-tests compared median post-test results between interns and students, with a p-value <0.05 considered significant.
Results: A total of 153 participants were enrolled, the majority being males (78.4%, n = 120) and medical students (73.9%, n = 113). Among the 40 interns, 55% (n = 22) were doctors, 30% (n = 12) were midwives, and 15% (n = 6) were nurses. The study participants showed an increase in knowledge, with median post-test scores higher than pre-test scores for all participants [63% (interquartile ranges, IQR: 57-71%) versus 49% (42-54%), with a median difference of 14% (8-23%), p < 0.001].
Conclusion: The SBT effectively imparts key knowledge competencies to the interns and fifth-year medical students. We recommend that SBT be included as part of the course units that students should take and for continuous medical education for qualified healthcare workers in resource-limited settings.
{"title":"Efficacy of the Gulu University Reproductive Health Simulation Training for final year medical students and interns: a before-and-after study.","authors":"Pebalo Francis Pebolo, Jerom Okot, Felix Bongomin, Silvia Awor, Baifa Arwinyo, Sande Ojara, Jimmyy Opee, Ayikoru Jackline, Eric Ssennuni, Simple Ouma","doi":"10.1177/26334941241251967","DOIUrl":"10.1177/26334941241251967","url":null,"abstract":"<p><strong>Background: </strong>Reproductive health emergencies, such as postpartum hemorrhage, contribute significantly to maternal and neonatal morbidity and mortality in Uganda due to knowledge and skills gaps. Medical interns, intern midwives, and nurses are crucial as frontline healthcare workers in responding to these emergencies. Our proposed hands-on strategy involves comprehensive simulation-based training (SBT) to equip these healthcare workers with the essential knowledge to manage common reproductive health emergencies and procedures in the country.</p><p><strong>Objectives: </strong>The study aimed to assess the effectiveness of comprehensive SBT in improving the knowledge of interns and fifth-year medical students on reproductive health emergencies and procedures at Gulu University and its Teaching Hospitals in Uganda.</p><p><strong>Design: </strong>A before-and-after study.</p><p><strong>Methods: </strong>A 4-day SBT was conducted for fifth-year medical students and interns (nurses, midwives, and doctors) at Gulu University Teaching Hospitals, focusing on reproductive health emergencies. Pre- and post-tests with 40 multiple-choice questions were used to evaluate knowledge enhancement, the scores were summarized as medians and interquartile ranges. Paired sample <i>t</i>-tests was used to test the difference in pre- and post-test scores. Independent sample <i>t</i>-tests compared median post-test results between interns and students, with a <i>p</i>-value <0.05 considered significant.</p><p><strong>Results: </strong>A total of 153 participants were enrolled, the majority being males (78.4%, <i>n</i> = 120) and medical students (73.9%, <i>n</i> = 113). Among the 40 interns, 55% (<i>n</i> = 22) were doctors, 30% (<i>n</i> = 12) were midwives, and 15% (<i>n</i> = 6) were nurses. The study participants showed an increase in knowledge, with median post-test scores higher than pre-test scores for all participants [63% (interquartile ranges, IQR: 57-71%) <i>versus</i> 49% (42-54%), with a median difference of 14% (8-23%), <i>p</i> < 0.001].</p><p><strong>Conclusion: </strong>The SBT effectively imparts key knowledge competencies to the interns and fifth-year medical students. We recommend that SBT be included as part of the course units that students should take and for continuous medical education for qualified healthcare workers in resource-limited settings.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11127575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}